Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture

NCT00481585 is registered in ClinicalTrials.gov with Hackensack Meridian Health as lead sponsor.

NCT NCT00481585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00481585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture
Lead sponsor
Hackensack Meridian Health
Phase
Observational
Overall status
Terminated
Start date
May 31, 2007
Completion date
Not reported
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer